220 related articles for article (PubMed ID: 26398872)
1. Olanzapine in the Management of Difficult to Control Nausea and Vomiting in a Palliative Care Population: A Case Series.
MacKintosh D
J Palliat Med; 2016 Jan; 19(1):87-90. PubMed ID: 26398872
[TBL] [Abstract][Full Text] [Related]
2. A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients.
Fonte C; Fatigoni S; Roila F
Crit Rev Oncol Hematol; 2015 Aug; 95(2):214-21. PubMed ID: 25779971
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine in the treatment of refractory nausea and vomiting: a case report and review of the literature.
Langley-DeGroot M; Ma JD; Hirst J; Roeland EJ
J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):148-52. PubMed ID: 26095486
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine for intractable nausea and vomiting in palliative care patients not receiving chemotherapy.
Atkinson SR
J Palliat Med; 2014 May; 17(5):503-4. PubMed ID: 24708452
[No Abstract] [Full Text] [Related]
5. Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction.
Kaneishi K; Kawabata M; Morita T
J Pain Symptom Manage; 2012 Oct; 44(4):604-7. PubMed ID: 22771132
[TBL] [Abstract][Full Text] [Related]
6. Use of olanzapine for the relief of nausea and vomiting in patients with advanced cancer: a multicenter survey in Japan.
Kaneishi K; Nishimura K; Sakurai N; Imai K; Matsuo N; Takahashi N; Okamoto K; Suga A; Sano H; Maeda I; Nishina H; Yamaguchi T; Morita T; Iwase S
Support Care Cancer; 2016 Jun; 24(6):2393-5. PubMed ID: 26838020
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review].
Benze G; Geyer A; Alt-Epping B; Nauck F
Schmerz; 2012 Sep; 26(5):481-99. PubMed ID: 22983450
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine for nausea and vomiting.
Licup N
Am J Hosp Palliat Care; 2010 Sep; 27(6):432-4. PubMed ID: 20508243
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-dose olanzapine on duloxetine-related nausea and vomiting for the treatment of major depressive disorder.
Zhong Z; Zhang Y; Han H; Huang Z; Wang J; Chen M; Zhang J
J Clin Psychopharmacol; 2014 Aug; 34(4):495-8. PubMed ID: 24943388
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting.
Chanthawong S; Subongkot S; Sookprasert A
J Med Assoc Thai; 2014 Mar; 97(3):349-55. PubMed ID: 25123016
[TBL] [Abstract][Full Text] [Related]
11. The Benefits of Olanzapine in Palliating Symptoms.
Davis MP; Sanger GJ
Curr Treat Options Oncol; 2020 Nov; 22(1):5. PubMed ID: 33244634
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine for intractable nausea in palliative care patients.
Jackson WC; Tavernier L
J Palliat Med; 2003 Apr; 6(2):251-5. PubMed ID: 12854942
[TBL] [Abstract][Full Text] [Related]
13. Treating nausea and vomiting in palliative care: a review.
Glare P; Miller J; Nikolova T; Tickoo R
Clin Interv Aging; 2011; 6():243-59. PubMed ID: 21966219
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy.
Abe M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Takekuma M; Hirashima Y
Biomed Res Int; 2015; 2015():956785. PubMed ID: 26425564
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly or moderately emetogenic chemotherapy: a randomized, double-blind, placebo-controlled study.
Mizukami N; Yamauchi M; Koike K; Watanabe A; Ichihara K; Masumori N; Yamakage M
J Pain Symptom Manage; 2014 Mar; 47(3):542-50. PubMed ID: 23856100
[TBL] [Abstract][Full Text] [Related]
16. Management of nausea and vomiting in palliative care.
Neoh K; Adkinson L; Montgomery V; Hurlow A
Br J Hosp Med (Lond); 2014 Jul; 75(7):391-2, 394-6. PubMed ID: 25040518
[TBL] [Abstract][Full Text] [Related]
17. Levomepromazine for nausea and vomiting in palliative care.
Cox L; Darvill E; Dorman S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009420. PubMed ID: 26524693
[TBL] [Abstract][Full Text] [Related]
18. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
Natale JJ
Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Olanzapine for Symptom Relief in Cancer Patients.
Nakagawa N; Suzuki M
J Pain Palliat Care Pharmacother; 2022 Dec; 36(4):216-222. PubMed ID: 36250742
[TBL] [Abstract][Full Text] [Related]
20. Patient-perceived symptomatic benefits of olanzapine treatment for nausea and vomiting in patients with advanced cancer who received palliative care through consultation teams: a multicenter prospective observational study.
Maeda I; Satomi E; Kiuchi D; Nishijima K; Matsuda Y; Tokoro A; Tagami K; Matsumoto Y; Naito A; Morita T; Iwase S; ; Otani H; Odagiri T; Watanabe H; Mori M; Matsuda Y; Nagaoka H; Mayuzumi M; Kanai Y; Sakamoto N; Ariyoshi K
Support Care Cancer; 2021 Oct; 29(10):5831-5838. PubMed ID: 33742244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
